Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beran

Showing results (151-160 of 251) with videos related to

Pageof 26
Sort By:
Leukemia & Lymphoma|April 11, 2003
Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemiaM J Keating, S O'Brien, D Kontoyiannis, et al.
Blood|December 1, 1988
Detection of leukemic clone maturation in vivo by premature chromosome condensationW N Hittelman, P Agbor, I Petkovic, et al.
Cancer|September 15, 1988
Effect of differentiation-inducing agents on oncogene expression in a chronic myelogenous leukemia cell lineA Eisbruch, M Blick, M J Evinger-Hodges, et al.
Cancer Genetics and Cytogenetics|August 1, 1987
Molecular characteristics of chronic myelogenous leukemia in blast crisisM Blick, P Romero, M Talpaz, et al.
Blood|June 1, 1993
Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agentM J Keating, S O'Brien, H Kantarjian, et al.
Soudni Lekarstvi|June 26, 2012
Immunohistochemistry and serum values of S-100B, glial fibrillary acidic protein, and hyperphosphorylated neurofilaments in brain injuriesD Vajtr, O Benada, P Linzer, et al.
Cancer|January 15, 1995
Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up resultsJ E Cortes, M Talpaz, M Beran, et al.
The American Journal of Medicine|February 1, 1991
Efficacy of fludarabine, a new adenine nucleoside analogue, in patients with prolymphocytic leukemia and the prolymphocytoid variant of chronic lymphocytic leukemiaH M Kantarjian, C Childs, S O'Brien, et al.
Cytokines and Molecular Therapy|March 1, 1995
High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF)E H Estey, H M Kantarjian, S O'Brien, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|October 24, 2023
Depression in Uveal Melanoma Survivorship: Examining Psychological Predictors of Adjustment in the First Year Following DiagnosisMegan M Hoch, James J MacDonald, Alexandra Jorge-Miller, et al.
Pageof 26

Showing results (151-160 of 251) with videos related to

Sort By:
Pageof 26
Leukemia & Lymphoma|April 11, 2003
Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemiaM J Keating, S O'Brien, D Kontoyiannis, et al.
Blood|December 1, 1988
Detection of leukemic clone maturation in vivo by premature chromosome condensationW N Hittelman, P Agbor, I Petkovic, et al.
Cancer|September 15, 1988
Effect of differentiation-inducing agents on oncogene expression in a chronic myelogenous leukemia cell lineA Eisbruch, M Blick, M J Evinger-Hodges, et al.
Cancer Genetics and Cytogenetics|August 1, 1987
Molecular characteristics of chronic myelogenous leukemia in blast crisisM Blick, P Romero, M Talpaz, et al.
Blood|June 1, 1993
Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agentM J Keating, S O'Brien, H Kantarjian, et al.
Soudni Lekarstvi|June 26, 2012
Immunohistochemistry and serum values of S-100B, glial fibrillary acidic protein, and hyperphosphorylated neurofilaments in brain injuriesD Vajtr, O Benada, P Linzer, et al.
Cancer|January 15, 1995
Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up resultsJ E Cortes, M Talpaz, M Beran, et al.
The American Journal of Medicine|February 1, 1991
Efficacy of fludarabine, a new adenine nucleoside analogue, in patients with prolymphocytic leukemia and the prolymphocytoid variant of chronic lymphocytic leukemiaH M Kantarjian, C Childs, S O'Brien, et al.
Cytokines and Molecular Therapy|March 1, 1995
High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF)E H Estey, H M Kantarjian, S O'Brien, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|October 24, 2023
Depression in Uveal Melanoma Survivorship: Examining Psychological Predictors of Adjustment in the First Year Following DiagnosisMegan M Hoch, James J MacDonald, Alexandra Jorge-Miller, et al.
Pageof 26